Package 0615-8377-39
Brand: divalproex sodium
Generic: divalproex sodiumPackage Facts
Identity
Package NDC
0615-8377-39
Digits Only
0615837739
Product NDC
0615-8377
Description
30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8377-39)
Marketing
Marketing Status
Brand
divalproex sodium
Generic
divalproex sodium
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "efe6fc7b-e709-4f0d-ba7f-ffb7a87ad155", "openfda": {"unii": ["644VL95AO6"], "rxcui": ["1099563", "1099569"], "spl_set_id": ["319bbead-bec8-4bb7-9ecb-b2e161c44b8d"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8377-39)", "package_ndc": "0615-8377-39", "marketing_start_date": "20210203"}], "brand_name": "Divalproex sodium", "product_id": "0615-8377_efe6fc7b-e709-4f0d-ba7f-ffb7a87ad155", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "0615-8377", "generic_name": "Divalproex sodium", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "500 mg/1"}], "application_number": "ANDA209286", "marketing_category": "ANDA", "marketing_start_date": "20200918", "listing_expiration_date": "20261231"}